Financhill
Back

Biogen, Inc. Stock Predictions

Biogen, Inc. Stock Forecast

  • Over the next 52 weeks, Biogen, Inc. has on average historically risen by 38.2% based on the past 34 years of stock performance.
  • Biogen, Inc. has risen higher in 24 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 70.59%
  • Is Biogen, Inc. Stock Undervalued?
    The current Biogen, Inc. [BIIB] share price is $192.08. The Score for BIIB is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • BIIB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Biogen, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Biogen, Inc. has on average historically risen by 38.2% based on the past 34 years of stock performance.

Biogen, Inc. Stock Rating

Buy
52
Biogen, Inc. (BIIB) is a Buy

Is Biogen, Inc. overpriced?

  • Biogen, Inc. has risen higher in 24 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 70.59%

Biogen, Inc. Stock Price History

Is BIIB stock going to rise?

  • The current trend is moderately bullish and BIIB is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biogen.com

52-Week Data

52-Week High:
202.41
52-Week Low:
110.04

Prediction Charts

Market Cap:
28.2B
Price in USD:
192.08
Volume:
993.3K
Beta:
0.86

Technical Analysis

SMA50:
179.51
SMA100:
168.71
SMA200:
150.33
52-Wk Change:
40.53%

Stock Predictions

  • Is Biogen, Inc. stock public?
    Yes, Biogen, Inc. is a publicly traded company.
  • What is the Biogen, Inc. stock quote today?
    The Biogen, Inc. stock price is 192.08 USD today.
  • How to buy Biogen, Inc. stock online?
    You can buy Biogen, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-30 177.09 179.89 180.14 175.96
Feb-2 179.30 179.09 180.76 177.58
Feb-3 177.79 176.76 182.67 176.19
Feb-4 177.25 185.45 186.24 177.10
Feb-5 184.87 185.36 187.73 184.54
Feb-6 187.01 201.18 202.41 184.60
Feb-9 199.83 193.81 201.00 191.88
Feb-10 194.07 188.99 195.72 188.74
Feb-11 188.35 191.20 192.00 187.20
Feb-12 190.15 195.50 196.00 189.00
Feb-13 196.27 196.52 199.50 195.52
Feb-17 197.46 195.62 200.29 193.37
Feb-18 195.32 194.13 195.68 193.11
Feb-19 193.51 192.08 195.00 191.05

Biogen, Inc. Earnings

Biogen, Inc. Earnings Report: Per Share Biogen, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Biogen, Inc. Forecast Revenue Growth

Biogen, Inc. Stock Analysis: Historical quarterly revenues per share for Biogen, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.66 per share, an increase this year of $0.64 per share, and an increase next year of $0.65 per share.

* Biogen, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.